An, G., Jin, J., Cai, Z., Jing, H., Fu, C., He, P., Xia, Z., Liu, R., Li, L., Gai, X., Zhang, H., Zhu, D., Luo, X., Sun, B., Xu, H., Zhou, L., Campagna, M., Masterson, T. J., Lau, B. W., Renaud, T., Heuck, C., Singh, I., Vishwamitra, D. and Qiu, L. (2020) “Talquetamab, a GPRC5D×CD3 bispecific antibody, in Chinese patients with relapsed/refractory multiple myeloma: efficacy and safety from the phase 1/2 MonumenTAL-1 study”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2025.287334.